Definition
The pharmacotherapies collected in this data cluster are recommended for the management of acute coronary syndromes (ACS) in the national guidelines. The following pharmacotherapies are collected as part of this data cluster:
- Aspirin
- Angiotensin converting enzyme (ACE) inhibitor
- Angiotensin II receptor blocker
- Antithrombin
- Beta-blocker
- Clopidogrel
- Fibrinolytic
- Glycoprotein IIb/IIIa receptor antagonist
- Statin
The pharmacotherapy cluster collects information on the type of pharmacotherapies prescribed and the timing of each prescription.
Metadata items in this Data Set Specification
Below is a list of all the components within this Dataset Specification.
Each entry includes the item name, whether the item is optional, mandatory or conditional and the maximum times the item can occur in a dataset.
If the items must occur in a particular order in the dataset, the sequence number is included before the item name.
Data Elements
| Reference | Data Element | Data Type | Length | Inclusion | # |
|---|---|---|---|---|---|
|
Person with acute coronary syndrome—pharmacotherapy type prescribed in hospital, code N[N]
Specific Information:
Codes provided for each of those prescribed during this hospital presentation.
|
Number | 2 | mandatory | 10 | |
|
Person with acute coronary syndrome—pharmacotherapy type taken post discharge from hospital, code N[N]
Specific Information:
To be provided at the follow-up visit following discharge from the hospital for each of the relevant pharmacotherapy types prescribed.
|
Number | 2 | mandatory | 7 | |
|
Person—fibrinolytic drug administered, code N
Conditional Inclusion:
If prescribed, provide the fibrinolytic drug administered.
|
Number | 1 | conditional | 1 | |
|
Person—intravenous fibrinolytic therapy date, DDMMYYYY
Conditional Inclusion:
If prescribed, provide the date when the fibrinolytic therapy is administered.
|
Date/Time | 8 | conditional | 1 | |
|
Person—intravenous fibrinolytic therapy time, hhmm
Conditional Inclusion:
If prescribed, provide the time when the fibrinolytic therapy is administered.
|
Date/Time | 4 | conditional | 1 | |
|
Person—reason for non prescription of pharmacotherapy, code N
Conditional Inclusion:
To be provided for each of the pharmacotherapies listed in the data element 'Pharmacotherapy type prescribed for acute coronary syndrome in hospital' not prescribed.
|
Number | 1 | conditional | 9 | |
|
Person—timing of ACE-inhibitor prescription, code N
Conditional Inclusion:
If prescribed, provide a phase for each time ACE-inhibitor therapy is prescribed.
|
Number | 1 | conditional | 5 | |
|
Person—timing of angiotensin II receptor blocker prescription, code N
Conditional Inclusion:
If prescribed, provide a phase for each time angiotensin II receptor blocker therapy is prescribed.
|
Number | 1 | conditional | 5 | |
|
Person—timing of antithrombin therapy prescription, code N
Conditional Inclusion:
If prescribed, provide a phase for each time antithrombin therapy is prescribed
|
Number | 1 | conditional | 4 | |
|
Person—timing of aspirin prescription, code N
Conditional Inclusion:
If prescribed, provide a phase for each time aspirin therapy is prescribed.
|
Number | 1 | conditional | 5 | |
|
Person—timing of beta-blocker prescription, code N
Conditional Inclusion:
If prescribed, provide a phase for each time beta-blocker therapy is prescribed.
|
Number | 1 | conditional | 5 | |
|
Person—timing of clopidogrel prescription, code N
Conditional Inclusion:
If prescribed, provide a phase for each time clopidogrel therapy is prescribed.
|
Number | 1 | conditional | 5 | |
|
Person—timing of glycoprotein IIb/IIIa inhibitor prescription, code N
Conditional Inclusion:
If prescribed, provide a phase for each time glycoprotein IIb/IIIa inhibitor therapy is prescribed.
|
Number | 1 | conditional | 4 | |
|
Person—timing of statin prescription, code N
Conditional Inclusion:
If prescribed, provide a phase for each time statin therapy is prescribed.
|
Number | 1 | conditional | 5 |
References
National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand. Guidelines for the management of acute coronary syndromes 2006. Med J Aust 2006; 184; S1-S32. © MJA 2006
This content Based on Australian Institute of Health and Welfare material. Attribution provided as required under the AIHW CC-BY licence.
This content Based on Australian Institute of Health and Welfare material. Attribution provided as required under the AIHW CC-BY licence.
Related content
| Relation | Count |
|---|---|
| As a numerator in an Indicator | 0 |
| As a denominator in an Indicator | 0 |
| As a disaggregation in an Indicator | 0 |